Given the reported functions of TFF3 in modulating RTK-mediated cellular functions [18, 30], including the data herein, it may be thus reasoned that RTK inhibition in cancer will be rendered more efficacious by TFF3 depletion or inhibition. The gene discussed is TFF3; the disease is cancer.